Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

KC Pharmaceuticals

Tracked across 11 events · 157 articles · First seen May 07, 2025 · Last active Jul 05, 2026

Sentiment
18
Attention
7
Events
11
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
Impact: The KC Pharmaceuticals issued new advice warning against prolonged use of nasal decongestant sprays.
Jan 08, 2026 · 6 articles
2 -10
Domestic
Impact: KC Pharmaceuticals accepted the resignation of its finance head, Rajkumar Bafna, due to India — Delhi's air pollution, highlighting potential challenges in retaining talent in affected regions.
Dec 28, 2025 · 11 articles
4 70
Tech
Impact: KC Pharmaceuticals, a subsidiary of Suzhou Ribo Life Science Company, is a key collaborator in the siRNA partnership with KC Pharmaceuticals, Inc., successfully reaching a drug nomination milestone for MASH therapies.
Jul 02, 2026 · 7 articles
2 10
Business
Impact: KC Pharmaceuticals is one of the publicly traded companies presenting at the conference, seeking to attract investors and showcase its innovations.
Apr 02, 2026 · 7 articles
7 55
International
Impact: KC Pharmaceuticals is vertically integrating the entire supply chain for authentic herbs, accelerating the global expansion of Chinese TCM and heritage wellness brands.
Jun 15, 2026 · 87 articles
4 10
Domestic
Impact: Professor Claire Anderson, president of the KC Pharmaceuticals, affirms the safety of paracetamol use during pregnancy, citing extensive safe use and recent studies.
Sep 22, 2025 · 7 articles
2 50
Regulatory
Impact: The KC Pharmaceuticals is involved in the establishment of joint oversight committees with the Nigeria — National Drug Law Enforcement Agency to strengthen monitoring of regulated medicines and improve intelligence sharing.
Jun 26, 2026 · 7 articles
4 10
Business
Impact: KC Pharmaceuticals became a new shareholder in Adani Group as part of the acquisition settlement.
Jul 02, 2026 · 6 articles
2 0
Business
Impact: KC Pharmaceuticals is a majority-owned subsidiary of Lobe Sciences and is mentioned as part of Lobe's strategic development, though not directly impacted by this specific private placement.
Apr 11, 2026 · 7 articles
3 0
Business
Impact: Adamas Pharmaceuticals>>> was sold to KC Pharmaceuticals>>>.
May 19, 2026 · 6 articles
2 0
Business
Apr 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track KC Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.